Cargando…
Placenta‐Derived Decidua Stromal Cells for Treatment of Severe Acute Graft‐Versus‐Host Disease
Severe acute graft‐versus‐host disease (GVHD) is a life‐threatening complication after allogeneic hematopoietic stem cell transplantation (HSCT). The placenta protects the fetus from the mother's immune system. We evaluated placenta‐derived decidua stromal cells (DSCs), which differ from bone m...
Autores principales: | Ringden, Olle, Baygan, Arjang, Remberger, Mats, Gustafsson, Britt, Winiarski, Jacek, Khoein, Bita, Moll, Guido, Klingspor, Lena, Westgren, Magnus, Sadeghi, Behnam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5866941/ https://www.ncbi.nlm.nih.gov/pubmed/29533533 http://dx.doi.org/10.1002/sctm.17-0167 |
Ejemplares similares
-
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic Cystitis
por: Baygan, Arjang, et al.
Publicado: (2017) -
Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells
por: Sadeghi, Behnam, et al.
Publicado: (2019) -
Preclinical Toxicity Evaluation of Clinical Grade Placenta-Derived Decidua Stromal Cells
por: Sadeghi, Behnam, et al.
Publicado: (2019) -
Mesenchymal Stromal Cells in Pediatric Hematopoietic Cell Transplantation a Review and a Pilot Study in Children Treated With Decidua Stromal Cells for Acute Graft-versus-Host Disease
por: Ringdén, Olle, et al.
Publicado: (2020) -
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
por: Ringdén, Olle, et al.
Publicado: (2022)